Alexion Pharmaceuticals, Inc. (ALXN)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
09-Jun-20 5:01 PM
View: 
Law Anne-Marie
EVP, Chief Experience Officer
Alexion Pharmaceuticals, Inc. (ALXN) 08-Jun-20Payment of Exercise 2,561$114.61$293,516.00(6%)
43.98K to 41.42K
(2%)
09-Jun-20 5:05 PM
View: 
Franchini Indrani Lall
EVP, Chief Compliance Officer
Alexion Pharmaceuticals, Inc. (ALXN) 08-Jun-20Payment of Exercise 1,403$114.61$160,798.00(4%)
36.47K to 35.07K
(2%)
09-Jun-20 4:59 PM
View: 
Orloff John J
EVP, Research & Development
Alexion Pharmaceuticals, Inc. (ALXN) 08-Jun-20Payment of Exercise 2,784$114.61$319,074.00(6%)
47.31K to 44.53K
(2%)
09-Jun-20 5:05 PM
View: 
Franchini Indrani Lall
EVP, Chief Compliance Officer
Alexion Pharmaceuticals, Inc. (ALXN) 08-Jun-20Market Sale (Planned) 6,853$114.69$785,981.00(20%)
35.07K to 28.22K
(2%)
09-Jun-20 4:58 PM
View: 
Goff Brian
EVP & Chief Commercial Officer
Alexion Pharmaceuticals, Inc. (ALXN) 08-Jun-20Payment of Exercise 1,642$114.61$188,190.00(3%)
49.66K to 48.02K
(2%)
18-May-20 5:10 PM
View: 
Dunsire Deborah
Director
Alexion Pharmaceuticals, Inc. (ALXN) 14-May-20Grant 4,409----57%
7.72K to 12.13K
18-May-20 5:12 PM
View: 
Friedman Paul A
Director
Alexion Pharmaceuticals, Inc. (ALXN) 14-May-20Grant 3,468----50%
6.88K to 10.35K
18-May-20 6:57 PM
View: 
Baker Bros Advisors LLC
Director
Alexion Pharmaceuticals, Inc. (ALXN) 14-May-20Grant 9,314----< 1%
9.0M to 9.01M
18-May-20 5:17 PM
View: 
Reinsdorf Judith A
Director
Alexion Pharmaceuticals, Inc. (ALXN) 14-May-20Grant 4,063----55%
7.45K to 11.52K
18-May-20 5:20 PM
View: 
Rummelt Andreas
Director
Alexion Pharmaceuticals, Inc. (ALXN) 14-May-20Grant 3,468----16%
22.15K to 25.61K
18-May-20 5:22 PM
View: 
Brennan David R
Director
Alexion Pharmaceuticals, Inc. (ALXN) 14-May-20Grant 5,896----51%
11.64K to 17.54K
18-May-20 5:14 PM
View: 
Nader Francois
Director
Alexion Pharmaceuticals, Inc. (ALXN) 14-May-20Grant 4,409----64%
6.88K to 11.29K
18-May-20 5:15 PM
View: 
Coughlin Christopher J
Director
Alexion Pharmaceuticals, Inc. (ALXN) 14-May-20Grant 6,242----19%
33.41K to 39.66K
18-May-20 5:18 PM
View: 
Mollen John T
Director
Alexion Pharmaceuticals, Inc. (ALXN) 14-May-20Grant 3,468----38%
9.23K to 12.7K
31-Mar-20 5:04 PM
View: 
Hantson Ludwig
CEO
Director
Alexion Pharmaceuticals, Inc. (ALXN) 30-Mar-20Payment of Exercise 3,202$85.43$273,547.00(2%)
193.86K to 190.66K
18-Mar-20 6:46 PM
View: 
Baker Bros Advisors LLC
Director
Alexion Pharmaceuticals, Inc. (ALXN) 18-Mar-20Private Purchase 81,379$82.01$6,673,930.00< 1%
8.92M to 9.0M
18-Mar-20 6:45 PM
View: 
Baker Bros Advisors LLC
Director
Alexion Pharmaceuticals, Inc. (ALXN) 18-Mar-20Private Purchase 50,902$79.76$4,059,790.00< 1%
8.86M to 8.92M
18-Mar-20 6:45 PM
View: 
Baker Bros Advisors LLC
Director
Alexion Pharmaceuticals, Inc. (ALXN) 17-Mar-20Private Purchase 102,421$76.51$7,836,580.001%
8.76M to 8.86M
18-Mar-20 6:45 PM
View: 
Baker Bros Advisors LLC
Director
Alexion Pharmaceuticals, Inc. (ALXN) 16-Mar-20Private Purchase 265,298$78.76$20,894,800.003%
8.5M to 8.76M
03-Mar-20 6:30 PM
View: 
Hantson Ludwig
CEO
Director
Alexion Pharmaceuticals, Inc. (ALXN) 02-Mar-20Payment of Exercise 8,406$90.54$761,079.00(4%)
202.27K to 193.86K
03-Mar-20 6:18 PM
View: 
Goff Brian
EVP & Chief Commercial Officer
Alexion Pharmaceuticals, Inc. (ALXN) 02-Mar-20Payment of Exercise 1,401$90.54$126,847.00(3%)
51.06K to 49.66K
03-Mar-20 6:21 PM
View: 
Law Anne-Marie
EVP, Chief Experience Officer
Alexion Pharmaceuticals, Inc. (ALXN) 02-Mar-20Payment of Exercise 1,308$90.54$118,426.00(3%)
45.29K to 43.98K
03-Mar-20 6:16 PM
View: 
Franchini Indrani Lall
EVP, Chief Compliance Officer
Alexion Pharmaceuticals, Inc. (ALXN) 02-Mar-20Payment of Exercise 1,267$90.54$114,714.00(3%)
37.74K to 36.47K
03-Mar-20 6:20 PM
View: 
Sarin Aradhana
EVP, CFO
Alexion Pharmaceuticals, Inc. (ALXN) 02-Mar-20Payment of Exercise 883$90.54$79,946.80(2%)
35.64K to 34.76K
03-Mar-20 6:31 PM
View: 
Chiniara Ellen
EVP & Chief Legal Officer
Alexion Pharmaceuticals, Inc. (ALXN) 02-Mar-20Payment of Exercise 1,263$90.54$114,352.00(5%)
26.16K to 24.9K
03-Mar-20 6:26 PM
View: 
Orloff John J
EVP, Research & Development
Alexion Pharmaceuticals, Inc. (ALXN) 02-Mar-20Payment of Exercise 1,396$90.54$126,394.00(3%)
48.67K to 47.27K
03-Mar-20 6:28 PM
View: 
Bazarko Daniel
SVP, Controller, CAO
Alexion Pharmaceuticals, Inc. (ALXN) 02-Mar-20Payment of Exercise 886$90.53$80,209.60(4%)
25.21K to 24.32K
03-Mar-20 6:16 PM
View: 
Franchini Indrani Lall
EVP, Chief Compliance Officer
Alexion Pharmaceuticals, Inc. (ALXN) 28-Feb-20Grant 9,520----34%
28.22K to 37.74K
03-Mar-20 6:20 PM
View: 
Sarin Aradhana
EVP, CFO
Alexion Pharmaceuticals, Inc. (ALXN) 28-Feb-20Grant 10,880----44%
24.76K to 35.64K
03-Mar-20 6:21 PM
View: 
Law Anne-Marie
EVP, Chief Experience Officer
Alexion Pharmaceuticals, Inc. (ALXN) 28-Feb-20Grant 10,200----29%
35.09K to 45.29K
03-Mar-20 6:31 PM
View: 
Chiniara Ellen
EVP & Chief Legal Officer
Alexion Pharmaceuticals, Inc. (ALXN) 28-Feb-20Grant 10,200----64%
15.96K to 26.16K
03-Mar-20 6:26 PM
View: 
Orloff John J
EVP, Research & Development
Alexion Pharmaceuticals, Inc. (ALXN) 28-Feb-20Grant 10,880----29%
37.79K to 48.67K
03-Mar-20 6:28 PM
View: 
Bazarko Daniel
SVP, Controller, CAO
Alexion Pharmaceuticals, Inc. (ALXN) 28-Feb-20Grant 3,927----18%
21.28K to 25.21K
03-Mar-20 6:30 PM
View: 
Hantson Ludwig
CEO
Director
Alexion Pharmaceuticals, Inc. (ALXN) 28-Feb-20Grant 44,201----28%
158.06K to 202.27K
03-Mar-20 6:23 PM
View: 
Carino Tanisha
EVP & CCAO
Alexion Pharmaceuticals, Inc. (ALXN) 28-Feb-20Grant 9,520----108%
8.78K to 18.3K
03-Mar-20 6:18 PM
View: 
Goff Brian
EVP & Chief Commercial Officer
Alexion Pharmaceuticals, Inc. (ALXN) 28-Feb-20Grant 10,880----27%
40.18K to 51.06K
02-Mar-20 10:53 AM
View: 
Bazarko Daniel
SVP, Controller, CAO
Alexion Pharmaceuticals, Inc. (ALXN) 27-Feb-20Payment of Exercise 216$92.97$20,081.50(1%)
21.5K to 21.28K
10-Feb-20 4:58 PM
View: 
Goff Brian
EVP & Chief Commercial Officer
Alexion Pharmaceuticals, Inc. (ALXN) 07-Feb-20Payment of Exercise 1,594$102.97$164,134.00(4%)
41.78K to 40.18K
10-Feb-20 4:56 PM
View: 
Bazarko Daniel
SVP, Controller, CAO
Alexion Pharmaceuticals, Inc. (ALXN) 07-Feb-20Payment of Exercise 851$102.97$87,627.50(4%)
22.35K to 21.5K
10-Feb-20 4:57 PM
View: 
Franchini Indrani Lall
EVP, Chief Compliance Officer
Alexion Pharmaceuticals, Inc. (ALXN) 07-Feb-20Payment of Exercise 1,406$102.97$144,776.00(5%)
29.63K to 28.22K
10-Feb-20 5:00 PM
View: 
Hantson Ludwig
CEO
Director
Alexion Pharmaceuticals, Inc. (ALXN) 07-Feb-20Payment of Exercise 12,771$102.97$1,315,030.00(7%)
170.84K to 158.06K
03-Mar-20 6:31 PM
View: 
Chiniara Ellen
EVP & Chief Legal Officer
Alexion Pharmaceuticals, Inc. (ALXN) 15-Dec-19Grant 54$93.86$5,068.44< 1%
24.9K to 24.95K
03-Mar-20 6:26 PM
View: 
Orloff John J
EVP, Research & Development
Alexion Pharmaceuticals, Inc. (ALXN) 15-Dec-19Grant 38$93.86$3,566.68< 1%
47.27K to 47.31K
04-Dec-19 6:36 PM
View: 
Sarin Aradhana
EVP, CFO
Alexion Pharmaceuticals, Inc. (ALXN) 02-Dec-19Payment of Exercise 5,441$113.20$615,921.00(18%)
30.2K to 24.76K
(4%)
04-Dec-19 6:52 PM
View: 
Bazarko Daniel
SVP, Controller, CAO
Alexion Pharmaceuticals, Inc. (ALXN) 02-Dec-19Payment of Exercise 1,185$113.20$134,142.00(5%)
23.54K to 22.35K
(4%)
02-Dec-19 4:37 PM
View: 
Carino Tanisha
EVP & CCAO
Alexion Pharmaceuticals, Inc. (ALXN) 29-Nov-19Grant 8,777----100%
0 to 8.78K
15-Jul-19 5:01 PM
View: 
Clancy Paul J
EVP, Chief Financial Officer
Alexion Pharmaceuticals, Inc. (ALXN) 11-Jul-19Payment of Exercise 5,230$124.20$649,566.00(5%)
95.68K to 90.45K
6%
02-Jul-19 4:41 PM
View: 
Franchini Indrani Lall
EVP, Chief Compliance Officer
Alexion Pharmaceuticals, Inc. (ALXN) 01-Jul-19Private Sale (Planned) 4,500$132.78$597,510.00(13%)
34.13K to 29.63K
24-Jun-19 4:45 PM
View: 
Sarin Aradhana
Chief Strategy & Business Off
Alexion Pharmaceuticals, Inc. (ALXN) 21-Jun-19Private Sale (Planned) 578$132.00$76,296.00(2%)
30.78K to 30.2K
11-Jun-19 6:37 PM
View: 
Law Anne-Marie
EVP, Chief Experience Officer
Alexion Pharmaceuticals, Inc. (ALXN) 07-Jun-19Payment of Exercise 2,563$118.61$303,997.00(7%)
37.66K to 35.09K
2%